Business Context and Reporting Period
This Form 8-K, dated June 29, 2020, reports preliminary, unaudited financial results for Landec Corporation (LNDC) for the fiscal fourth quarter ended May 31, 2020. Landec operates two primary businesses: Curation Foods (plant-based foods) and Lifecore Biomedical (contract development and manufacturing). The filing details the impact of the COVID-19 pandemic on operations and outlines "Project SWIFT," a strategic initiative to restructure Curation Foods.
Key Financial Metrics (Q4 FY2020)
| Metric | Consolidated | Lifecore | Curation Foods |
|---|---|---|---|
| Revenue | $156.1 million | $25.5 million | $130.6 million |
| Net Income (Loss) | $(14.6)M to $(17.6)M | $4.8 million | $(15.4)M to $(18.4)M |
| Adjusted EBITDA | $12.6M to $14.6M | $7.5 million | $5.8M to $7.8M |
| Diluted Net Loss Per Share | $(0.50) to $(0.60) | N/A | N/A |
| Adjusted Diluted EPS | $0.01 to $0.06 | N/A | N/A |
Debt and Liquidity: As of May 31, 2020, $191.4 million of indebtedness was outstanding under the Credit Agreement, maturing on September 23, 2021. The company incurred a one-time waiver fee of approximately $0.3 million due to covenant non-compliance in March 2020.
Material Changes and Operational Updates
- Project SWIFT Restructuring: Landec announced the closure of Curation Foods' underutilized manufacturing facility in Hanover, PA, with operations consolidating to Guadalupe, CA, and Bowling Green, OH by September 2020. This is expected to generate approximately $11 million in annualized cost savings.
- COVID-19 Impact: Curation Foods faced demand shifts toward lower-margin products and order volatility, reducing margins. Lifecore experienced temporary manufacturing inefficiencies due to new safety protocols, though these have since been resolved.
- Impairment Charges: Preliminary analysis indicates potential impairment of goodwill and intangible assets for Curation Foods (specifically O Olive Oil & Vinegar and Yucatan brands), estimated between $14 million and $16 million.
Guidance, Outlook, and Risks
Management expects the operational enhancements from Project SWIFT to improve gross and adjusted EBITDA margins in fiscal 2021, translating to more consistent profitable growth. Proceeds from the sale of the Hanover facility assets are intended to pay down debt and strengthen the balance sheet.
Risks and Contingencies:
- Covenant Compliance: The company was not in compliance with minimum monthly EBITDA and maximum capital expenditure covenants through May 31, 2020. A limited default waiver was granted for March 2020, and discussions are ongoing to secure a waiver through May 31, 2020.
- Forward-Looking Uncertainty: Risks include the timing of cost savings realization, the ability to negotiate credit agreement amendments, and continued volatility in consumer shopping patterns.
Investor Verification Checklist
- Verify the finalization of the goodwill and intangible asset impairment analysis for Curation Foods, currently estimated at $14M-$16M.
- Confirm the status of the credit agreement waiver negotiations with creditors to ensure compliance through May 31, 2020.
- Monitor the timeline and execution of the Hanover, PA facility closure and asset sale to validate the projected $11 million in annualized savings.
- Review the final audited financial statements expected in early August 2020 to confirm the preliminary loss ranges and Adjusted EBITDA figures.